Overview

Cubicin(R) for Complicated Post-surgical Wound Infections

Status:
Terminated
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to describe the clinical efficacy of CUBICIN therapy in patients with superficial and deep post-surgical Gram-positive wound infections
Phase:
Phase 4
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Treatments:
Daptomycin